Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years

Hormozgan University of Medical Sciences100 enrolled

Overview

Acute upper respiratory tract infections are the most commmon infections in children and are associated with complications such as acute otitis media, sinusitis and pneumonia. Echinacea is widely used for treatment of upper respiratoty tract infections. The aim of this study is to evaluate its efficacy as prophilaxis in children 1-5 years old.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

DOUBLE

Enrollment

100

Conditions

Upper Respiratory Tract Infections

Interventions

EchinaceaDRUG

0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old

PlaceboDRUG

Placebo (0.5ml daily for children 1-2 years old and 2ml daily for children 2-5 years old) for 3 months

Eligibility

Sex: ALLMin age: 1 YearMax age: 5 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Childrens 1-5 years old Exclusion Criteria: * Wheezing in previous 3 months requiring bronchodilatator * History of hyperactive reactive airway * using steroid or Echinacea * chronic pulmonary of cardiac disease * Acute respiratory disease within one week before study * Allergic rhinitis * Allergy to Echinacea * avoiding to participate in the study

Locations (1)

Hormozgan University of Medical Sciences (HUMS)

Bandar Abbas, Hormozgan, Iran

Outcomes

Primary Outcomes

occurrence of upper respiratory tract infection diagnosed by physician according to history and physical examination and laboratory tests if was necessary

Time frame: 6 months

Secondary Outcomes

Drug side effects

Time frame: 6 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.